人工智能技术的进步用于预测天然药物的药理性质
Tianyu Xu1, Yuemiao Xu1, Jinger Zhang1
1Zhejiang Chinese Medical University, Hangzhou, 310053, China.
Life sciences
|December 31, 2025
概括
人工智能 (AI) 通过选化合物和预测目标来加速天然产品药物发现. 人工智能还通过预测ADMET特性来优化药物开发,节省时间和资源.
科学领域:
- 药理学 药理学是指药理学的学科.
- 计算化学计算化学
- 药物发现 药物发现 药物发现
背景情况:
- 自然产品是富含药理活性化合物的丰富来源.
- 传统的药物发现是耗时和昂贵的.
- 人工智能 (AI),包括机器学习 (ML) 和深度学习 (DL),提供先进的计算工具.
研究的目的:
- 审查人工智能在预测天然药物的药理性质方面的应用.
- 概述人工智能模型构建原则和最近的进展.
- 讨论使用人工智能开发天然药物的挑战和机遇.
主要方法:
- 利用现有的数据集和实验数据进行AI模型培训.
- 选天然产品化合物潜在的生物活性.
- 预测与疾病相关的药物标.
- 预测吸收,分布,新陈代谢,分泌和毒性 (ADMET) 的特性.
主要成果:
- 人工智能显著加快了从天然产品中识别化合物的速度.
- 人工智能可以准确预测药物标和ADMET配置文件.
- 早期预测ADMET属性可以降低开发成本和时间表.
结论:
- 人工智能是自然产品药物发现和开发中的转型工具.
- 人工智能应用提高了药物候选物识别和表征的效率并降低了成本.
- 对人工智能方法的进一步研究和开发将释放出自然医学的更大潜力.
相关概念视频
Structure-Activity Relationships and Drug Design
1.6K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.6K
Measurement of Bioavailability: Pharmacodynamic Methods
209
Pharmacodynamic methods provide insights into a drug's effects on physiological processes over time and play a crucial role in understanding bioavailability and therapeutic efficacy. These methods can be broadly classified into acute pharmacological and therapeutic response approaches, each with distinct mechanisms and applications.The acute pharmacological response method directly correlates a drug's physiological effects, such as ECG or pupil diameter changes, to its time course in the body.
209
Drug Discovery: Overview
10.9K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
10.9K
Pharmacokinetic Models: Comparison and Selection Criterion
304
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
304
Pharmacokinetic Models: Overview
1.8K
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
1.8K
Dosage Regimens: Partial Pharmacokinetic Parameters
133
It is not uncommon for complete drug pharmacokinetic profiles to remain elusive in pharmacokinetics. This necessitates certain educated assumptions by pharmacokineticists to determine appropriate dosage regimens without comprehensive pharmacokinetic data from animal or human studies. One prevalent assumption is setting the bioavailability factor, denoted as F, to 1 or 100%. This assumption caters to the scenario where a drug doesn't achieve full systemic absorption, resulting in the patient...
133


